Found 7 matching trials
PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers
PHASE1This is an open-label, parallel-group study to compare the pharmacokinetics...
Location
Avail Clinical Research
Companion Protocol for Methacetin Breath Test (MBT) in Conatus Protocol IDN-6556-14
N/ATo validate the ability of the Methacetin Breath Test (MBT) to detect clini...
Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension
PHASE2This is a multicenter, randomized, double-blind, placebo-controlled trial i...
Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis
PHASE2This is a multicenter, double-blind, randomized, placebo-controlled trial i...
Location
University of Alabama at Birmingham
PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
PHASE1This is an open-label, parallel-group study to compare the pharmacokinetics...
Location
Avail Clinical Research
Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF
PHASE2The study will evaluate the pharmacokinetics, pharmacodynamics, safety and ...
Location
University of Alabama at Birmingham
A Caspase Inhibitor in Chronic Hepatitis C (HCV) Patients
PHASE2The purpose of this study is to determine if IDN-6556, when given orally, i...
Location
Mayo Clinic Hospital